ProCE Banner Series

Modern Approaches to CMV Prevention in Solid Organ Transplant Recipients

Join expert faculty as they discuss how to integrate the latest scientific data and developments in antivirals and laboratory monitoring into optimized CMV management approaches in SOT recipients.

Unable to join us in Boston? Register now for the online Simulcast!

  ACPE
  | AMA
Who Should Attend

This program is intended for infectious diseases physicians, pharmacists, and other healthcare professionals who care for patients at risk for CMV following solid organ transplantation.

All Events

Modern Approaches to CMV Prevention in Solid Organ Transplant Recipients

Past Events

October

11

2023

7:30 PM - 9:00 PM Eastern Time (ET)

In-personVirtual

Omni Boston Hotel at the Seaport, 450 Summer Street, Boston, Massachusetts 02210

Faculty

ProCE Banner Faculty
Atul Humar, MD

Director of Transplantation 
Department of Medicine 
University of Toronto 
Toronto, Ontario, Canada 

ProCE Banner Faculty
Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

ProCE Banner Faculty
Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Topics

  • Introduction
  • Modernizing Preventative Approaches
  • Beyond Prevention
  • Complex Clinical Scenarios: Using the Full Armamentarium Against the Troll of Transplantation
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to integrate the latest scientific data and developments in antivirals and laboratory monitoring into optimized CMV management approaches in SOT recipients. 

Target Audience
This program is intended for infectious diseases physicians, pharmacists, and other healthcare professionals who care for patients at risk for CMV following solid organ transplantation. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply evidence-based monitoring strategies to CMV management approaches in SOT recipients
  • Integrate emerging antiviral strategies for CMV prevention into optimized management plans for SOT recipients
  • Individualize CMV prevention strategies for SOT recipients in complex clinical scenarios including late CMV infections and secondary prophylaxis

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-154-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.